GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Other Long Term Assets

Eris Lifesciences (BOM:540596) Other Long Term Assets : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences Other Long Term Assets?

Eris Lifesciences's other long-term assets for the quarter that ended in Dec. 2024 was ₹0 Mil.

Eris Lifesciences's quarterly other long-term assets increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹4,020 Mil) but then stayed the same from Sep. 2024 (₹4,020 Mil) to Dec. 2024 (₹0 Mil).

Eris Lifesciences's annual other long-term assets declined from Mar. 2022 (₹6,755 Mil) to Mar. 2023 (₹3,010 Mil) but then increased from Mar. 2023 (₹3,010 Mil) to Mar. 2024 (₹3,891 Mil).

Eris Lifesciences Other Long Term Assets Historical Data

The historical data trend for Eris Lifesciences's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences Other Long Term Assets Chart

Eris Lifesciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,864.11 4,981.51 6,755.37 3,009.93 3,890.54

Eris Lifesciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3,890.54 - 4,020.00 -

Eris Lifesciences Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Eris Lifesciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (BOM:540596) » Definitions » Other Long Term Assets
Comparable Companies
BOM:533573 BOM:544210 BOM:506820 BOM:524558 BOM:532300 BOM:524742 BOM:524816 BOM:530019 BOM:506943 BOM:543322 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
ERIS:India
Address
Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Website
https://www.eris.co.in
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences Headlines

No Headlines